This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2000 Mar 25;355(9209):1033-4.

doi: 10.1016/S0140-6736(00)02031-6.

From star signs to trial guidelines

R Horton¹

Affiliations

PMID: 10744086
DOI: 10.1016/S0140-6736(00)02031-6

Comment

From star signs to trial guidelines

R Horton. Lancet. 2000.

. 2000 Mar 25;355(9209):1033-4.

doi: 10.1016/S0140-6736(00)02031-6.

Author

R Horton¹

Affiliation

¹ The Lancet, London, UK.

PMID: 10744086
DOI: 10.1016/S0140-6736(00)02031-6

No abstract available

PubMed Disclaimer

Comment in

Tumour site, sex, and survival in colorectal cancer.
Buyse M, Piedbois Y, Piedbois P, Gray R. Buyse M, et al. Lancet. 2000 Sep 2;356(9232):858. doi: 10.1016/S0140-6736(05)73441-3. Lancet. 2000. PMID: 11022959 No abstract available.

Comment on

Subgroup analysis and other (mis)uses of baseline data in clinical trials.
Assmann SF, Pocock SJ, Enos LE, Kasten LE. Assmann SF, et al. Lancet. 2000 Mar 25;355(9209):1064-9. doi: 10.1016/S0140-6736(00)02039-0. Lancet. 2000. PMID: 10744093

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.